European Journal of Medicinal Chemistry

Article	Citations
Oxidative stress mitigation by antioxidants - An overview on their chemistry and influences on health status	305
Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: A minireview	261
β-lactam antibiotics: An overview from a medicinal chemistry perspective	220
Current trends in computer aided drug design and a highlight of drugs discovered via computational techniques: A review	213
Alzheimer’s disease and its treatment by different approaches: A review	192
An insight on medicinal attributes of 1,2,4-triazoles	156
Recent developments of gallic acid derivatives and their hybrids in medicinal chemistry: A review	151
Application of sulfoximines in medicinal chemistry from 2013 to 2020	133
RNA-dependent RNA polymerase (RdRp) inhibitors: The current landscape and repurposing for the COVID-19 pandemic	132
Bioactive pyrrole-based compounds with target selectivity	122
A comprehensive review of monoamine oxidase inhibitors as Anti-Alzheimer’s disease agents: A review	121
hERG toxicity assessment: Useful guidelines for drug design	115
The development of Coronavirus 3C-Like protease (3CLpro) inhibitors from 2010 to 2020	115
Research progress of mTOR inhibitors	114
Ferrocene-containing hybrids as potential anticancer agents: Current developments, mechanisms of action and structure-activity relationships	113
Antibacterial activities with the structure-activity relationship of coumarin derivatives	112
Design and discovery of boronic acid drugs	110
Proteolysis targeting chimera (PROTAC) in drug discovery paradigm: Recent progress and future challenges	109
Small molecule selenium-containing compounds: Recent development and therapeutic applications	105
Anticancer property of ginsenoside Rh2 from ginseng	99
Celastrol: Progresses in structure-modifications, structure-activity relationships, pharmacology and toxicology	97
Chalcone hybrids as privileged scaffolds in antimalarial drug discovery: A key review	96
The importance of indole and azaindole scaffold in the development of antitumor agents	94
Indole-based derivatives as potential antibacterial activity against methicillin-resistance Staphylococcus aureus (MRSA)	91
Pyrazole-based analogs as potential antibacterial agents against methicillin-resistance staphylococcus aureus (MRSA) and its SAR elucidation	88

In vitro and in vivo anticancer activity of tridentate thiosemicarbazone copper complexes: Unravelling an unexplored pharmacological target	84
Overview of cannabidiol (CBD) and its analogues: Structures, biological activities, and neuroprotective mechanisms in epilepsy and Alzheimer’s disease	82
Discovery of potent epidermal growth factor receptor (EGFR) degraders by proteolysis targeting chimera (PROTAC)	81
Synthetic and medicinal perspective of quinolines as antiviral agents	78
A promising antiviral candidate drug for the COVID-19 pandemic: A mini-review of remdesivir	77
Plant isoquinoline alkaloids: Advances in the chemistry and biology of berberine	77
Treatment for liver cancer: From sorafenib to natural products	73
Recent advance on PTP1B inhibitors and their biomedical applications	73
Sulfonamide derivatives as potential anti-cancer agents and their SARs elucidation	72
A review: Pharmacological aspects of metal based 1,2,4-triazole derived Schiff bases	72
Recent advances in the medicinal chemistry of carbonic anhydrase inhibitors	72
Recent advancements in the development of bioactive pyrazoline derivatives	71
Agonist and antagonist ligands of toll-like receptors 7 and 8: Ingenious tools for therapeutic purposes	71
Discovery of natural anti-inflammatory alkaloids: Potential leads for the drug discovery for the treatment of inflammation	70
Current development of CBP/p300 inhibitors in the last decade	70
A medicinal chemistry perspective of drug repositioning: Recent advances and challenges in drug discovery	69
The application of isatin-based multicomponent-reactions in the quest for new bioactive and druglike molecules	69
1,2,3-Triazole-containing hybrids with potential antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA)	68
PROTACs to address the challenges facing small molecule inhibitors	67
Current scenario of indole derivatives with potential anti-drug-resistant cancer activity	67
Discovery of PROTAC BCL-XL degraders as potent anticancer agents with low on-target platelet toxicity	66
Therapeutic strategies to overcome cisplatin resistance in ovarian cancer	65
Recent accomplishments on the synthetic/biological facets of pharmacologically active 1H-1,2,3-triazoles	65
FDA-approved pyrimidine-fused bicyclic heterocycles for cancer therapy: Synthesis and clinical application	64
Histone deacetylase 3 (HDAC3) inhibitors as anticancer agents: A review	64
Design, synthesis and structure-activity relationships of 4-phenyl-1H-1,2,3-triazole phenylalanine derivatives as novel HIV-1 capsid inhibitors with promising antiviral activities	64
Synthesis and biological evaluation of coumarin derivatives as α-glucosidase inhibitors	64
A review: Biologically active 3,4-heterocycle-fused coumarins	63
Recent progress on HDAC inhibitors with dual targeting capabilities for cancer treatment	63
Antimicrobial drugs bearing guanidine moieties: A review	63
Azithromycin: The First Broad-spectrum Therapeutic	62
Camptothecin's journey from discovery to WHO Essential Medicine: Fifty years of promise	62
A review on the structure and pharmacological activity of phenylethanoid glycosides	62
Novel quinazoline-based EGFR kinase inhibitors: A review focussing on SAR and molecular docking studies (2015-2019)	61
Developments of CRBN-based PROTACs as potential therapeutic agents	61
Chemotherapy and chemo-resistance in nasopharyngeal carcinoma	61
Exploration of carbamide derived pyrimidine-thioindole conjugates as potential VEGFR-2 inhibitors with anti-angiogenesis effect	61
Activity-based protein profiling: Recent advances in medicinal chemistry	60
Discovery of novel resorcinol diphenyl ether-based PROTAC-like molecules as dual inhibitors and degraders of PD-L1	60
Resveratrol – A comprehensive review of recent advances in anticancer drug design and development	60
Pt(II) and Au(III) complexes containing Schiff-base ligands: A promising source for antitumor treatment	59
Recent advancements in the development of heterocyclic anti-inflammatory agents	59
Design and synthesis of selective degraders of EGFRL858R/T790M mutant	59
Structural insights of oxindole based kinase inhibitors as anticancer agents: Recent advances	58
Potentials of nanotechnology in treatment of methicillin-resistant Staphylococcus aureus	58
Penicillin binding protein 2a: An overview and a medicinal chemistry perspective	58
Recent advances in DNA gyrase-targeted antimicrobial agents	58
A key review on oxadiazole analogs as potential methicillin-resistant Staphylococcus aureus (MRSA) activity: Structure-activity relationship studies	58
Discovery of potent small molecule PROTACs targeting mutant EGFR	58
Contemporary approaches and future perspectives of antibacterial photodynamic therapy (aPDT) against methicillin-resistant Staphylococcus aureus (MRSA): A systematic review	57

Chemistry, biosynthesis and biological activity of terpenoids and meroterpenoids in bacteria and fungi isolated from different marine habitats	57
Chalcones: Unearthing their therapeutic possibility as monoamine oxidase B inhibitors	57
Cancer multidrug-resistance reversal by ABCB1 inhibition: A recent update	57
Research progress of indole compounds with potential antidiabetic activity	57
Recent advances in the design and discovery of synthetic tyrosinase inhibitors	57
Isoxazole derivatives as anticancer agent: A review on synthetic strategies, mechanism of action and SAR studies	57
Quercetin derivatives: Drug design, development, and biological activities, a review	57
Fight against novel coronavirus: A perspective of medicinal chemists	56
Toll-like receptor 4 (TLR4) inhibitors: Current research and prospective	56
Improved SARS-CoV-2 Mpro inhibitors based on feline antiviral drug GC376: Structural enhancements, increased solubility, and micellar studies	56
A review on ferulic acid and analogs based scaffolds for the management of Alzheimer’s disease	56
Recent research progress on natural small molecule bibenzyls and its derivatives in Dendrobium species	56
Effective degradation of EGFRL858R+T790M mutant proteins by CRBN-based PROTACs through both proteosome and autophagy/lysosome degradation systems	55
First orally bioavailable prodrug of proteolysis targeting chimera (PROTAC) degrades cyclin-dependent kinases 2/4/6 in vivo	55
Exosomes from different cells: Characteristics, modifications, and therapeutic applications	54
Synthesis and biological evaluation of organoselenium (NSAIDs-SeCN and SeCF3) derivatives as potential anticancer agents	54
Membrane active 7-thiazoxime quinolones as novel DNA binding agents to decrease the genes expression and exert potent anti-methicillin-resistant Staphylococcus aureus activity	54
Monocarboxylate transporter 1 and 4 inhibitors as potential therapeutics for treating solid tumours: A review with structure-activity relationship insights	53
The role of imidazole and benzimidazole heterocycles in Chagas disease: A review	53
Pyrimidine-based EGFR TK inhibitors in targeted cancer therapy	52
Natural and synthetic coumarins as antileishmanial agents: A review	52
Synthesis and anticancer activity of thiourea derivatives bearing a benzodioxole moiety with EGFR inhibitory activity, apoptosis assay and molecular docking study	52
PROTAC: A promising technology for cancer treatment	52
Synthesis of adenine dinucleosides SAM analogs as specific inhibitors of SARS-CoV nsp14 RNA cap guanine-N7-methyltransferase	52
Therapeutic potential of targeting SHP2 in human developmental disorders and cancers	51
Therapeutic progression of quinazolines as targeted chemotherapeutic agents	51
DYRK1A inhibitors for disease therapy: Current status and perspectives	51
Design, synthesis and biological evaluation of novel pyrazole sulfonamide derivatives as dual COX-2/5-LOX inhibitors	50
Anticancer potential of spirocompounds in medicinal chemistry: A pentennial expedition	50
Induced protein degradation of histone deacetylases 3 (HDAC3) by proteolysis targeting chimera (PROTAC)	49
Hydroxamate siderophores: Natural occurrence, chemical synthesis, iron binding affinity and use as Trojan horses against pathogens	49
β-Carbolines as potential anticancer agents	49
Antimalarial application of quinones: A recent update	49
Xanthenes in Medicinal Chemistry – Synthetic strategies and biological activities	49
Novel 2-indolinone thiazole hybrids as sunitinib analogues: Design, synthesis, and potent VEGFR-2 inhibition with potential anti-renal cancer activity	49
Development of a Brigatinib degrader (SIAIS117) as a potential treatment for ALK positive cancer resistance	49
Recent progress in Keap1-Nrf2 protein-protein interaction inhibitors	49
Molecular hybrids: A five-year survey on structures of multiple targeted hybrids of protein kinase inhibitors for cancer therapy	49
The development of advanced structural framework as multi-target-directed ligands for the treatment of Alzheimer’s disease	49
Development of Mcl-1 inhibitors for cancer therapy	48
Targeting estrogen receptor α for degradation with PROTACs: A promising approach to overcome endocrine resistance	48
Discovery of unique thiazolidinone-conjugated coumarins as novel broad spectrum antibacterial agents	48
Kojic acid–natural product conjugates as mushroom tyrosinase inhibitors	48
1,2,3-Triazole-Chalcone hybrids: Synthesis, in vitro cytotoxic activity and mechanistic investigation of apoptosis induction in multiple myeloma RPMI-8226	48
New manganese(II), iron(II), cobalt(II), nickel(II) and copper(II) saccharinate complexes of 2,6-bis(2-benzimidazolyl)pyridine as potential anticancer agents	47
Small molecule therapeutics for tauopathy in Alzheimer’s disease: Walking on the path of most resistance	47
The nano delivery systems and applications of mRNA	47
Design, synthesis and in vivo evaluation of 3-arylcoumarin derivatives of rhenium(I) tricarbonyl complexes as potent antibacterial agents against methicillin-resistant Staphylococcus aureus (MRSA)	47
Inhibitors of gelatinases (MMP-2 and MMP-9) for the management of hematological malignancies	46
A comprehensive review on β-lapachone: Mechanisms, structural modifications, and therapeutic potentials	46
Natural heat shock protein 90 inhibitors in cancer and inflammation	46
Indole chalcones: Design, synthesis, in vitro and in silico evaluation against Mycobacterium tuberculosis	46
Discovery of selective CDK9 degraders with enhancing antiproliferative activity through PROTAC conversion	46
Anticancer boron-containing prodrugs responsive to oxidative stress from the tumor microenvironment	45
Anti-tuberculosis activity and its structure-activity relationship (SAR) studies of oxadiazole derivatives: A key review	45
Indomethacin-based PROTACs as pan-coronavirus antiviral agents	45
Pyridazine as a privileged structure: An updated review on anticancer activity of pyridazine containing bioactive molecules	45
Potent inhibitors of SARS-CoV-2 3C-like protease derived from N-substituted isatin compounds	45
Free radical scavengers: An overview on heterocyclic advances and medicinal prospects	45
Synergistic effects of curcumin and its analogs with other bioactive compounds: A comprehensive review	45
Pluronic-based nanovehicles: Recent advances in anticancer therapeutic applications	44
Imidazo[2,1-b] [1,3,4]thiadiazoles with antiproliferative activity against primary and gemcitabine-resistant pancreatic cancer cells	44
Vitamin D and its analogs as anticancer and anti-inflammatory agents	44
Inclusion of a 5-fluorouracil moiety in nitrogenous bases derivatives as human carbonic anhydrase IX and XII inhibitors produced a targeted action against MDA-MB-231 and T47D breast cancer cells	44
Comprehensive review for anticancer hybridized multitargeting HDAC inhibitors	44
Recent research progress of Uncaria spp. based on alkaloids: phytochemistry, pharmacology and structural chemistry	44
Functionalized quinoxalinones as privileged structures with broad-ranging pharmacological activities	43
The state of the art of PROTAC technologies for drug discovery	43
Coumarin–benzimidazole hybrids: A review of developments in medicinal chemistry	43
Recent advances of quinones as a privileged structure in drug discovery	43
Recent advances in DDR (DNA damage response) inhibitors for cancer therapy	43
Non-polyphenolic natural inhibitors of amyloid aggregation	43
Targeting mTOR for fighting diseases: A revisited review of mTOR inhibitors	43
3-Methylthiazolo[3,2-a]benzimidazole-benzenesulfonamide conjugates as novel carbonic anhydrase inhibitors endowed with anticancer activity: Design, synthesis, biological and molecular modeling studies	43
An insight in anti-malarial potential of indole scaffold: A review	42
The ups and downs of Poly(ADP-ribose) Polymerase-1 inhibitors in cancer therapy–Current progress and future direction	42
The heat shock response and small molecule regulators	42
Quinoline anticancer agents active on DNA and DNA-interacting proteins: From classical to emerging therapeutic targets	42
Targeting drug delivery system for platinum(Ⅳ)-Based antitumor complexes	42
A comprehensive description of GluN2B-selective N-methyl-D-aspartate (NMDA) receptor antagonists	42

Sulfonamide-based ring-fused analogues for CAN508 as novel carbonic anhydrase inhibitors endowed with antitumor activity: Design, synthesis, and in vitro biological evaluation	42
Current status and future prospects of p38α/MAPK14 kinase and its inhibitors	42
Discovery of thalidomide-based PROTAC small molecules as the highly efficient SHP2 degraders	42
Design and characterization of cereblon-mediated androgen receptor proteolysis-targeting chimeras	42
Epoxide containing molecules: A good or a bad drug design approach	42
Discovery of tertiary amide derivatives incorporating benzothiazole moiety as anti-gastric cancer agents in vitro via inhibiting tubulin polymerization and activating the Hippo signaling pathway	41
Drug repositioning: Progress and challenges in drug discovery for various diseases	41
Synthetic α-glucosidase inhibitors as promising anti-diabetic agents: Recent developments and future challenges	41
Dihydrofolate reductase inhibitors for use as antimicrobial agents	41
1,2,4-Oxadiazole topsentin analogs as staphylococcal biofilm inhibitors targeting the bacterial transpeptidase sortase A	41
Design, synthesis, and in vitro and in vivo anti-angiogenesis study of a novel vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitor based on 1,2,3-triazole scaffold	41
Small-molecule inhibitors of breast cancer-related targets: Potential therapeutic agents for breast cancer	40
Design, synthesis and biological evaluation of harmine derivatives as potent GSK-3β/DYRK1A dual inhibitors for the treatment of Alzheimer's disease	40
Design, synthesis and in vitro evaluation of novel SARS-CoV-2 3CLpro covalent inhibitors	40
Andrographolide and its derivatives: Current achievements and future perspectives	40
Meroterpenoids produced by fungi: Occurrence, structural diversity, biological activities, and their molecular targets	40
Antioxidant, anti-inflammatory and immunomodulatory roles of vitamins in COVID-19 therapy	40
Alzheimer's disease: Updated multi-targets therapeutics are in clinical and in progress	40
Identification of novel potent and non-toxic anticancer, anti-angiogenic and antimetastatic rhenium complexes against colorectal carcinoma	40
Novel strategies targeting bromodomain-containing protein 4 (BRD4) for cancer drug discovery	40
2-Aminothiazole: A privileged scaffold for the discovery of anti-cancer agents	39
Expanding the anticancer potential of 1,2,3-triazoles via simultaneously targeting Cyclooxygenase-2, 15-lipoxygenase and tumor-associated carbonic anhydrases	39
Discovery of highly potent tubulin polymerization inhibitors: Design, synthesis, and structure-activity relationships of novel 2,7-diaryl-[1,2,4]triazolo[1,5-a]pyrimidines	39
The new opportunities in medicinal chemistry of fourth-generation EGFR inhibitors to overcome C797S mutation	39
Recent advances of podophyllotoxin/epipodophyllotoxin hybrids in anticancer activity, mode of action, and structure-activity relationship: An update (2010–2020)	38
Design, synthesis, and biological evaluation of novel miconazole analogues containing selenium as potent antifungal agents	38
Discovery of novel purinylthiazolylethanone derivatives as anti-Candida albicans agents through possible multifaceted mechanisms	38
Optimal linker length for small molecule PROTACs that selectively target p38α and p38β for degradation	38
The antibacterial activity of fluoroquinolone derivatives: An update (2018–2021)	38
Cyclic tailor-made amino acids in the design of modern pharmaceuticals	38
Discovery of novel cell-penetrating and tumor-targeting peptide-drug conjugate (PDC) for programmable delivery of paclitaxel and cancer treatment	37
Anticancer activity of 4′-phenyl-2,2′:6′,2″-terpyridines – behind the metal complexation	37
Discovery of new phenyl sulfonyl-pyrimidine carboxylate derivatives as the potential multi-target drugs with effective anti-Alzheimer’s action: Design, synthesis, crystal structure and in-vitro biolog	37
Modulators of CFTR. Updates on clinical development and future directions	37
Efficient targeted oncogenic KRASG12C degradation via first reversible-covalent PROTAC	37
Novel NHC-coordinated ruthenium(II) arene complexes achieve synergistic efficacy as safe and effective anticancer therapeutics	37
Design, synthesis and biological evaluation of novel naturally-inspired multifunctional molecules for the management of Alzheimer’s disease	37
Discovery of metal-based complexes as promising antimicrobial agents	37
Emerging small-molecule inhibitors of the Bruton’s tyrosine kinase (BTK): Current development	37
Discovery of IAP-recruiting BCL-XL PROTACs as potent degraders across multiple cancer cell lines	37
Dual-target compounds for Alzheimer's disease: Natural and synthetic AChE and BACE-1 dual-inhibitors and their structure-activity relationship (SAR)	36
Janus kinases (JAKs): The efficient therapeutic targets for autoimmune diseases and myeloproliferative disorders	36
STING, a promising target for small molecular immune modulator: A review	36
2-substituted benzothiazoles as antiproliferative agents: Novel insights on structure-activity relationships	36
Bench-to-bedside: Innovation of small molecule anti-SARS-CoV-2 drugs in China	36
Design, synthesis and evaluation of new quinazolin-4-one derivatives as apoptotic enhancers and autophagy inhibitors with potent antitumor activity	36
p62 as a therapeutic target for tumor	36
Development of novel benzofuran-based SLC-0111 analogs as selective cancer-associated carbonic anhydrase isoform IX inhibitors	36
Design and synthesis of 3-(4-pyridyl)-5-(4-sulfamido-phenyl)-1,2,4-oxadiazole derivatives as novel GSK-3β inhibitors and evaluation of their potential as multifunctional anti-Alzheimer agents	36
Aldose reductase and protein tyrosine phosphatase 1B inhibitors as a promising therapeutic approach for diabetes mellitus	36
Elephantopinolide A-P, germacrane-type sesquiterpene lactones from Elephantopus scaber induce apoptosis, autophagy and G2/M phase arrest in hepatocellular carcinoma cells	36
Dammarane-type leads panaxadiol and protopanaxadiol for drug discovery: Biological activity and structural modification	36
Specific stabilization of promoter G-Quadruplex DNA by 2,6-disubstituted amidoanthracene-9,10-dione based dimeric distamycin analogues and their selective cancer cell cytotoxicity	35
Synthesis and biological activities of drugs for the treatment of osteoporosis	35
Design, preparation and evaluation of different branched biotin modified liposomes for targeting breast cancer	35
Development of MDM2 degraders based on ligands derived from Ugi reactions: Lessons and discoveries	35
Breaking down the cell wall: Strategies for antibiotic discovery targeting bacterial transpeptidases	35
New drug approvals for 2019: Synthesis and clinical applications	35
Synthesis and biological evaluation of gold(III) Schiff base complexes for the treatment of hepatocellular carcinoma through attenuating TrxR activity	35
Polypharmacological drug actions of recently FDA approved antibiotics	35
Design, synthesis, and bioevaluation of pyrazolo[1,5-a]pyrimidine derivatives as tubulin polymerization inhibitors targeting the colchicine binding site with potent anticancer activities	35
Hypoxia-activated nanomedicines for effective cancer therapy	35
Synthesis, and biological evaluation of 3,6-diaryl-[1,2,4]triazolo[4,3-a]pyridine analogues as new potent tubulin polymerization inhibitors	35
Factor XII/XIIa inhibitors: Their discovery, development, and potential indications	34
Novel 3-substituted coumarins as selective human carbonic anhydrase IX and XII inhibitors: Synthesis, biological and molecular dynamics analysis	34
Antioxidant activity of novel quinazolinones bearing sulfonamide: Potential radiomodulatory effects on liver tissues via NF-κB/ PON1 pathway	34
Medicinal chemistry updates of novel HDACs inhibitors (2020 to present)	34
Bridging free radical chemistry with drug discovery: A promising way for finding novel drugs efficiently	34
Recent advances in the design and development of formyl peptide receptor 2 (FPR2/ALX) agonists as pro-resolving agents with diverse therapeutic potential	34
Adamantane derivatives as potential inhibitors of p37 major envelope protein and poxvirus reproduction. Design, synthesis and antiviral activity	34
Non-invasive intranasal administration route directly to the brain using dendrimer nanoplatforms: An opportunity to develop new CNS drugs	34
Design, synthesis and evaluation of novel bis-substituted aromatic amide dithiocarbamate derivatives as colchicine site tubulin polymerization inhibitors with potent anticancer activities	34
Investigating the antibacterial activity of salen/salophene metal complexes: Induction of ferroptosis as part of the mode of action	34
Annual review of lysine-specific demethylase 1 (LSD1/KDM1A) inhibitors in 2021	33
Natural products from mangrove sediments-derived microbes: Structural diversity, bioactivities, biosynthesis, and total synthesis	33
Structure-activity relationship studies of phenothiazine derivatives as a new class of ferroptosis inhibitors together with the therapeutic effect in an ischemic stroke model	33
Poly ethylene glycol (PEG)-Related controllable and sustainable antidiabetic drug delivery systems	33
Development of triazolothiadiazine derivatives as highly potent tubulin polymerization inhibitors: Structure-activity relationship, in vitro and in vivo study	33
Design, synthesis, and biological evaluation of nitroisoxazole-containing spiro[pyrrolidin-oxindole] derivatives as novel glutathione peroxidase 4/mouse double minute 2 dual inhibitors that inhibit br	33
Targeting EZH2 for cancer therapy: From current progress to novel strategies	33
Advance of structural modification of nucleosides scaffold	33
Synthesis of some new benzoxazole derivatives and investigation of their anticancer activities	33
Purine/purine isoster based scaffolds as new derivatives of benzamide class of HDAC inhibitors	33
Synthesis and biological evaluation of 1,2,4-triazole derivatives as potential neuroprotectant against ischemic brain injury	33
Review of the development of BTK inhibitors in overcoming the clinical limitations of ibrutinib	33
Natural and nature-inspired stilbenoids as antiviral agents	33
N-alkylpiperidine carbamates as potential anti-Alzheimer’s agents	33
Developments of isoCombretastatin A-4 derivatives as highly cytotoxic agents	33
Aurora kinase inhibitors as potential anticancer agents: Recent advances	33
Recent applications of vinyl sulfone motif in drug design and discovery	32
New deferiprone derivatives as multi-functional cholinesterase inhibitors: design, synthesis and in vitro evaluation	32
Medicinal chemistry strategies for the development of protein tyrosine phosphatase SHP2 inhibitors and PROTAC degraders	32
PROTACs: New method to degrade transcription regulating proteins	32
An unanticipated discovery towards novel naphthalimide corbelled aminothiazoximes as potential anti-MRSA agents and allosteric modulators for PBP2a	32
Recent advance on carbamate-based cholinesterase inhibitors as potential multifunctional agents against Alzheimer's disease	32